Medication Guide App

GAVISCON COOL MINT LIQUID

Active substance: SODIUM BICARBONATE

View full screen / Print PDF » Download PDF ⇩

Transcript
RBH Artwork
and Print Specification
Trident Reference No:
Action / Version:
Brand:
Brand Platform:
Sub Platform:
Sub Brand:
Format:
Delivery:
Pack Size:
Country:
Date Created:
Date Modified:
RBH Contact:

Do not store above 30°C. Do not refrigerate or freeze.
Keep out of the reach and sight of children.

What is this product?

Cool Mint Flavour
Heartburn & Indigestion

0 000000 000000

Lori Glasgow

Gaviscon
Adult
Cool
Cool Liquid
Liquid
Bottle
150ml
UK
23/03/10
01/04/10

Artwork Type:
Component Code (2D if applicable):
Parent Technical Packaging
Specification:
Bulk Code (if applicable):

.

Dosage: For oral use. Shake well before use. Read the
package leaflet before use.

TR360542
C

XXXX

RB002888
D0006045

N/a

CAD Cam Ref: G-lbl-D0006045-155x60mm - P&R
Printer:
Regulatory Artwork - No Printer Required
Substrate:
Self Adhesive White Paper
Edgemark Position:
Pharmacode No/NE:

Pharmacode Reads This Way

N/a
N/A

Cutter - Does not print Guides- Does not print

Last Bar

First Bar
Print and Technical Colours
PANTONE Reflex Blue C

av scon Coo nt qu d.
Sodium alginate, sodium hydrogen carbonate and
calcium carbonate.
Read all of this leaflet carefully because it contains
important information for you.
This medicine is available without prescription.
However, you still need to take this medicine carefully
o get the best results from it.
or advice.
worsen or do not improve after 7 days.
please tell your doctor or pharmacist.
1. What is Gaviscon Cool Mint Liquid and what is it
used for?
2. Before you take Gaviscon Cool Mint Liquid.
. How to take Gaviscon Cool Mint Liquid.
. Possible side effects.
5. How to store Gaviscon Cool Mint Liquid.

6. Furt er in ormation.
1. WHAT IS GAVISCON COOL MINT LIQUID AND
WHAT IS IT USED FOR?
Gaviscon Cool Mint Liquid belongs to a group of
medicines called "reflux suppressants”, which form a
protective layer on top of the stomach contents to
prevent stomach acid escaping from the stomach
where it works into the food pipe causing pain and
discomfort.
This medicine is used for the treatment of symptoms
regurgitation, heartburn and indigestion (related to
reflux), for example, following meals, or during
pregnancy, or in patients with symptoms related to
reflux oesophagitis.
2. BEFORE YOU TAKE GAVISCON COOL MINT LIQUID
Do not take Gaviscon Cool Mint Liquid
any of the ingredients of Gaviscon Cool Mint Liquid
as very rarely difficulty in breathing and skin rashes
have occurred (see further information for a full list).
Take special care with Cool Mint Liquid
This medicine contains small amounts of sodium (6.2

Reflex Blue Tone

Varnish Generic

1

3

FLX

mmo per 10 m ) an calc um (1.6 mmo per 10 ml).
- If you have been advised to follow a diet restricted
in any of these please consult your doctor.
- Please also talk to your doctor regarding these salt
contents if you suffer or have suffered from
significant kidney or heart disease, as certain salts
could interfere with these diseases.
Please consult your doctor if you know you have
reduced amounts of gastric acid in your stomach, as
this product may be less effective.
If symptoms persist after 7 days consult your doctor.
Taking other medicines:
Do not take this product within two hours of taking
other medicines by mouth as it can interfere with the
action of some other medicines.
Please tell your doctor or pharmacist if you are
taking or have recently taken any other medicines
including medicines obtained without prescription.
Pregnancy and breast-feeding:
You can take this product if you are pregnant or
breast-feeding.
Important information about some of the ingredients
of Gaviscon Cool Mint Liquid
RB002888

2
FLX

FLX

PANTONE 320 C

PANTONE 116 C

PANTONE 185 C

4

5

6

FLX

FLX

FLX

PANTONE 2915 C
7
FLX

Colours

to m at ch recognised s

tandards

BARCODE INFO
Not Known
Barcode Type:
N/A
Barcode Number:
Magnification:
N/A
BWR:
N/A
Truncated by (smallest Bar): N/A
N/A
Encoded Data:
All other aspects of the bar code to conform
to the current GS1 Operating Manual or
other agreed commercial standard.

This product contains methyl E218 and propyl (E216)
para-hydroxybenzoates which may cause allergic
reactions (possibly delayed).
3. HOW TO TAKE GAVISCON COOL MINT LIQUID
For oral administration. Shake well before use.
Adults, including the elderly and children 12 years
and over: 10-20 ml after meals and at bedtime (up to
four times a day).
Children under 12 years: Should only be taken on
medical advice.
If you take more Gaviscon Cool Mint Liquid than you
should
If you take too much of this product it is unlikely to
cause you any harm. However, you may feel bloated.
Consult your doctor if this doesn’t go away.
If you forget to take Gaviscon Cool Mint Liquid
If you forget a dose it is not necessary to double the
dose next time, just carry on taking as before.
4. POSSIBLE SIDE EFFECTS
Like all medicines, Gaviscon Cool Mint Liquid can
cause side effects, although not everybody gets
them.
If you experience these side effects stop taking the

product an consu t your doctor mme ately. ery
rare (less than 1 in 10,000) chance of an allergic
reaction to the ingredients. Symptoms of this may
include skin rash, itching, difficulty breathing,
dizziness, or swelling of the face, lips, tongue or
throat.
If any of the side effects gets serious, or you notice
any side effects not listed in this leaflet, please tell
your doctor or pharmacist.
5. HOW TO STORE GAVISCON COOL MINT LIQUID
KEEP OUT OF THE REACH AND SIGHT OF CHILDREN
Do not use Gaviscon Cool Mint Liquid after the expiry
date which is stated on the label {EXP: month/year}.
The expiry date refers to the last day of that month.
Do not store above 30°C. Do not freeze or refrigerate
Check that the cap seal is unbroken before first using
this product.
Medicines should not be disposed of via wastewater
or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These
measures will help to protect the environment.
6. FURTHER INFORMATION
What Gaviscon Cool Mint Liquid contains

T e act ve su stances n eac 1 ml o ora
suspension contains 500 mg sodium alginate, 267 mg
sodium hydrogen carbonate and 160 mg calcium
carbonate as the active ingredients. The other
ingredients are carbomer, methyl (E218) and propyl
(E216) parahydroxy-benzoates, saccharin sodium,
sodium hydroxide, mint flavour no. 4, mint flavour no.
5 and purified water. This product does not contain
sugar or gluten.
What Gaviscon Cool Mint Liquid looks like and
contents of the pack
Gaviscon Cool Mint Liquid is an off-white suspension
with the odour and flavour of peppermint.
Gaviscon Cool Mint Liquid is available in bottles of
150 ml or 300 ml.
Marketing Authorisation Holder and Manufacturer
Reckitt Benckiser Healthcare (UK) Limited, Dansom
Lane, Hull, HU8 7DS.
This medicinal product is authorised in the member
states of the EA under the following names:
UK: Gaviscon Cool Mint Liquid.
This leaflet was last approved in February 2010.

Connaught House, Connaught Road,
Kingswood Business Park, Hull, HU7 3AP, England.
T: +44 (0) 1482 828100
Please note that any low resolution paper Canon colour
copies associated with this job should be referred to for
content, layout and colour separation only.
STUDIO USE ONLY

Lee Hardey

Sm•Art check results:

G=0; O=0; R=0; – LH – 01/04/10 11:03:26

v1.0

ARTWORK APPROVAL

RB002888

Approved by Sonoco Trident on behalf of Reckitt Benckiser
Signed:
Date:

CUSTOMER INFO:
Minimum Point Size = 6 pt
Horizontal scale = 78%

UNDER NO CIRCUMSTANCES SHOULD THIS
ARTWORK BE ALTERED WITHOUT PRIOR
PERMISSION FROM TRIDENT.
Tel. Alan Smith: +44 (0)1482 710304

NOT APPROVED FOR COLOUR

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web1)